Author:
Kolibianakis Efstratios,Bourgain Claire,Albano Carola,Osmanagaoglu Kaan,Smitz Johan,Van Steirteghem Andre,Devroey Paul
Subject
Obstetrics and Gynecology,Reproductive Medicine
Reference18 articles.
1. Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group;Borm;Hum Reprod,2000
2. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation;Fluker;Fertil Steril,2001
3. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin);Olivennes;Fertil Steril,2000
4. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group;Albano;Hum Reprod,2000
5. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation;Hum Reprod,2001
Cited by
300 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献